These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4678322)

  • 21. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
    Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
    [No Abstract]   [Full Text] [Related]  

  • 23. Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination.
    Hirose M; Hidaka Y; Miyazaki C; Ueda K; Yoshikawa H
    Scand J Infect Dis; 1997; 29(2):187-90. PubMed ID: 9181657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles prevention.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Jul; 36(26):409-18, 423-5. PubMed ID: 3110568
    [No Abstract]   [Full Text] [Related]  

  • 25. MEASLES VACCINATION. I. SEROLOGIC RESPONSES TO AN INACTIVATED VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S; CARLSTROEM G
    Arch Gesamte Virusforsch; 1963 Aug; 13():548-58. PubMed ID: 14085248
    [No Abstract]   [Full Text] [Related]  

  • 26. Altered reactivity to measles virus: local reactions following attenuated measles virus immunization in children who previously received a combination of inactivated and attenuated vaccines.
    Fulginiti VA; Arthur JH; Pearlman DS; Kempe CH
    Am J Dis Child; 1968 Jun; 115(6):671-6. PubMed ID: 4968323
    [No Abstract]   [Full Text] [Related]  

  • 27. [On vaccination against measles with live and attenuated virus (Schwarz strain)].
    Monaci V; Imperato C; Battistini A; Nardi G; Grzincich GL; Bellelli E; Mazzeo G
    Ann Sclavo; 1973; 15(3):134-40. PubMed ID: 4776383
    [No Abstract]   [Full Text] [Related]  

  • 28. Leads from the MMWR. Measles prevention.
    JAMA; 1987 Aug; 258(7):890-5. PubMed ID: 3613013
    [No Abstract]   [Full Text] [Related]  

  • 29. Notes on the effect of measles and measles vaccine in a virgin-soil population of South American Indians.
    Neel JV; Centerwall WR; Chagnon NA; Casey HL
    Am J Epidemiol; 1970 Apr; 91(4):418-29. PubMed ID: 4192799
    [No Abstract]   [Full Text] [Related]  

  • 30. [Measles incidence among children properly vaccinated against this infection].
    Bolotovskiĭ VM; Bebeshko VA; Titova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):32-6. PubMed ID: 4454882
    [No Abstract]   [Full Text] [Related]  

  • 31. MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S
    Br Med J; 1965 Mar; 1(5438):813-7. PubMed ID: 14258844
    [No Abstract]   [Full Text] [Related]  

  • 32. Measles vaccination.
    Kukla LF
    Compr Ther; 1977 Jun; 3(6):41-6. PubMed ID: 68846
    [No Abstract]   [Full Text] [Related]  

  • 33. Development and evaluation of the Moraten measles virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J; Whitman JE; Leagus MB
    JAMA; 1968 Oct; 206(3):587-90. PubMed ID: 5695578
    [No Abstract]   [Full Text] [Related]  

  • 34. [VIROLOGICAL AND CLINICAL OBSERVATIONS FOLLOWING ACTIVE MEASLES IMMUNIZATION].
    HAAS R; VIVELL O; GAEDECKE R; SIGNER E; SCHUMACHER H; BERTHOLD H
    Dtsch Med Wochenschr; 1965 Jan; 90():193-200. PubMed ID: 14240834
    [No Abstract]   [Full Text] [Related]  

  • 35. Measles (rubeola) in previously immunized children.
    Baratta RO; Ginter MC; Price MA; Walker JW; Skinner RG; Prather EC; David JK
    Pediatrics; 1970 Sep; 46(3):397-402. PubMed ID: 4195394
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on further attenuated live measles vaccine. V. Immunization test of CAM-A4 measles vaccine on handicapped children.
    Ueda S; Okuno Y; Sakamoto Y
    Biken J; 1970 Sep; 13(3):175-8. PubMed ID: 4249672
    [No Abstract]   [Full Text] [Related]  

  • 38. [Development of measles vaccination in Austria].
    Huber EG; Rannon L
    Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
    [No Abstract]   [Full Text] [Related]  

  • 39. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E
    Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885
    [No Abstract]   [Full Text] [Related]  

  • 40. Measles at Disneyland, a problem for all ages.
    Halsey NA; Salmon DA
    Ann Intern Med; 2015 May; 162(9):655-6. PubMed ID: 25751746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.